全文获取类型
收费全文 | 30854篇 |
免费 | 2951篇 |
国内免费 | 2246篇 |
专业分类
耳鼻咽喉 | 331篇 |
儿科学 | 366篇 |
妇产科学 | 373篇 |
基础医学 | 3664篇 |
口腔科学 | 570篇 |
临床医学 | 4125篇 |
内科学 | 4575篇 |
皮肤病学 | 384篇 |
神经病学 | 1597篇 |
特种医学 | 1151篇 |
外国民族医学 | 17篇 |
外科学 | 2814篇 |
综合类 | 5115篇 |
现状与发展 | 7篇 |
一般理论 | 6篇 |
预防医学 | 2340篇 |
眼科学 | 882篇 |
药学 | 3368篇 |
20篇 | |
中国医学 | 1830篇 |
肿瘤学 | 2516篇 |
出版年
2024年 | 105篇 |
2023年 | 501篇 |
2022年 | 1271篇 |
2021年 | 1608篇 |
2020年 | 1249篇 |
2019年 | 1099篇 |
2018年 | 1125篇 |
2017年 | 1113篇 |
2016年 | 1026篇 |
2015年 | 1420篇 |
2014年 | 1828篇 |
2013年 | 1692篇 |
2012年 | 2424篇 |
2011年 | 2567篇 |
2010年 | 1576篇 |
2009年 | 1264篇 |
2008年 | 1687篇 |
2007年 | 1635篇 |
2006年 | 1520篇 |
2005年 | 1509篇 |
2004年 | 1063篇 |
2003年 | 1016篇 |
2002年 | 870篇 |
2001年 | 676篇 |
2000年 | 597篇 |
1999年 | 604篇 |
1998年 | 409篇 |
1997年 | 363篇 |
1996年 | 274篇 |
1995年 | 287篇 |
1994年 | 252篇 |
1993年 | 180篇 |
1992年 | 202篇 |
1991年 | 190篇 |
1990年 | 140篇 |
1989年 | 138篇 |
1988年 | 133篇 |
1987年 | 101篇 |
1986年 | 81篇 |
1985年 | 64篇 |
1984年 | 29篇 |
1983年 | 43篇 |
1981年 | 18篇 |
1980年 | 13篇 |
1979年 | 15篇 |
1978年 | 7篇 |
1977年 | 8篇 |
1976年 | 7篇 |
1974年 | 7篇 |
1973年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
A. Roosaar L. Yin G. Sandborgh-Englund O. Nyrén T. Axéll 《Journal of oral pathology & medicine》2006,35(5):257-261
OBJECTIVES: The aim was to assess the natural course of oral lichen lesions (OLL) among unselected, non-consulting individuals. SUBJECTS AND METHODS: A cohort of 327 subjects with OLL, confirmed in 1973-1974 during a population-based survey in two Swedish municipalities, was followed through January 2002 via record linkages with nationwide and essentially complete registers. A sample of 80 drawn from the 194 surviving subjects who still resided in the area in 1993-1995 was invited for interview and oral re-examination. RESULTS: At the end of follow-up, one case of oral cancer was detected, while 0.4 were expected. The overall mortality among subjects with OLL was not significantly different from that in the 15,817 OLL-free subjects who participated in the initial population based survey in 1973-1974. The lesion had disappeared in 14 (39%) of 36 re-examined subjects with white OLLs in 1973-1974, and four (11%) had transformed into red types. In the corresponding group of 19 with red forms initially, five (26%) had become lesion free and four (21%) had switched to white types. Although the cohort size does not permit firm conclusions regarding oral cancer risk, the natural course over up to 30 years appears to be benign in the great majority. 相似文献
2.
以曼氏血吸虫的虫卵和成虫免疫家兔后所产生的特异性抗体,可用以日本血吸虫虫卵、尾蚴和成虫为抗原分别进行的COP,CHR和ELACIEP测出,表明两种人体血吸虫存有显著的交叉抗原成分。应用此种血清交叉反应性,以检测抗异种人体血吸虫的抗体,似有效而可取的,可用以辅助诊断援外回国人员是否感染国外人体血吸虫病。 相似文献
3.
4.
Gelin Xu Xinfeng Liu Wusheng Zhu Qin Yin Renliang Zhang Xiaobing Fan 《Blood coagulation & fibrinolysis》2007,18(2):193-197
This study evaluated the safety and efficacy of batroxobin in treating hyperfibrinogenemia for secondary stroke prevention. Patients with ischemic stroke or transient ischemic attack (TIA) were measured for plasma fibrinogen levels. Selected participants had concomitant hyperfibrinogenemia (plasma fibrinogen > or = 3.0 g/l). Patients enrolled between 1 July 2003 and 31 December 2004 were treated with batroxobin; patients enrolled between 1 January 2002 and 30 June 2003 were treated without batroxobin. Batroxobin was administered intermittently via intravenous injection at 3-monthly intervals. Patients in both groups were followed for 1 year. Any cerebrovascular events and suspected adverse events were recorded. In total, 112 ischemic stroke/TIA patients with concomitant hyperfibrinogenemia were enrolled, 52 being treated with batroxobin and 60 without batroxobin. Six patients (11.5%) with batroxobin and 16 patients (26.7%) without batroxobin had recurrent cerebral ischemic events during follow-up. Stroke/TIA recurrence in patients without batroxobin was higher than that in patients with batroxobin (P < 0.05). Two patients with batroxobin and two patients without batroxobin developed hemorrhagic stroke during follow-up. There were five deaths (9.6%) in the batroxobin group, and seven deaths (11.7%) in the nonbatroxobin group during follow-up (P > 0.05). Intermittent intravenous injection of batroxobin can efficiently reduce the risk for stroke/TIA recurrence in patients with concomitant hyperfibrinogenemia. 相似文献
5.
ZQ Yin MD SG Crewther PhD B Pirie BSc DP Crewther PhD 《Clinical & experimental ophthalmology》1997,25(4):107-109
Purpose: It was investigated whether alterations in neuronal structure and function occasioned by strabismic amblyopia also may be reflected in alterations in the expression on Y type neurons of a Cat-301 antibody sensitive antigen in the lateral geniculate nucleus (LGN) and cortex of our cat model of strabismic amblyopia. Methods/Results: The percentage of positively labelled cells was reduced in LGN laminae that received input from the deviated eye in strabismic amblyopic cats compared with normal cats. In the strabismic cortex, the density of immunopositive neurons was significantly reduced compared with normal, the effect being most pronounced in layer IV Conclusions: Despite previous physiological recordings indicating a decrease in X-cell associated acuity in strabismic amblyopia, the present findings imply that the changes in the early visual experience occasioned by strabismus also produce specific molecular changes in theY neuronal class. 相似文献
6.
神经移位修复臂丛神经根性撕脱伤 总被引:3,自引:2,他引:1
1987年7月~1994年6月,对21例臂丛神经根性撕脱伤采用神经移位修复。其中复合移位4组神经(膈神经、副神经、颈丛运动支、肋间神经)者1例,3组(膈神经、副神经、颈丛运动支)者6例,2组(膈神经、副神经)者9例,1组(膈神经或颈丛运动支或肋间神经)者5例。术中发现臂丛神经变异1例,对4例合并锁骨下动脉损伤者,在神经移位的同时进行血管修复,促进患肢的血液循环,有利于神经的康复。随访到19例,随访时间为8个月~6年2个月,优良率达73.7%。认为,神经移位术是修复神经根性撕裂伤的常规方法,合并血管损伤者也应同时修复,对促进神经功能恢复有利 相似文献
7.
8.
观察硒和维生素A(VA)对支原体肺炎的治疗效果.方法 采用双盲随机对照2×2析因实验设计,选择100例住院支原体肺炎患儿,分为补硒组26例,补VA组23例,补硒和VA组30例以及病例对照组21例,正常组21例.一次补硒量为1mg亚硒酸钠和/或15万单位VA,对照病例组给予常规治疗.结果 与对照组比,治疗后3个补充组的症状和体征缓解天数均有不同程度缩短(P<0.05),补硒组白细胞硒和谷胱甘肽过氧化物酶水平显著上升(P<0.05),补VA、补硒组血清VA水平上升(P<0.01),细胞免疫功能有所改善.结论 硒和VA有协同作用,补充硒或同时加VA,作为辅助治疗支原体肺炎的方法,安全、有效. 相似文献
9.
10.
Meng-Liang Zhou Ji-Xin Shi Chun-Hua Hang Hui-Lin Cheng Xiao-Ping Qi Lei Mao Ke-Fei Chen Hong-Xia Yin 《Journal of cerebral blood flow and metabolism》2007,27(9):1583-1592
Nuclear factor-kappaB (NF-kappaB) plays a key role in inflammation, which is involved in the development of cerebral vasospasm after subarachnoid hemorrhage (SAH). In the present study, we assessed the potential role of NF-kappaB in regulation of cerebral vasospasm. Nuclear factor-kappaB DNA-binding activity was measured in cultured vascular smooth muscle cells (VSMCs) treated with hemolysate and pyrrolidine dithiocarbamate (PDTC, 80 micromol/L), an inhibitor of NF-kappaB. Forty-two rabbits were divided into three groups: control, SAH, and PDTC groups (n=14 for each group). The caliber of the basilar artery was evaluated. Nuclear factor-kappaB DNA-binding activity and the gene expression levels of cytokines and adhesion molecules in the basilar artery were measured. Immunohistochemical study was performed to assess the expression and localization of tumor necrosis factor (TNF)-alpha, intercellular adhesion molecule (ICAM)-1, and myeloperoxidase (MPO). It was observed that NF-kappaB DNA-binding activity was significantly increased by treatment with hemolysate in cultured VSCMs, but this increase was suppressed by pretreatment with PDTC. Severe vasospasm was observed in the SAH group, which was attenuated in the PDTC group. Subarachnoid hemorrhage could induce increases of NF-kappaB DNA-binding activity and the gene expression levels of TNF-alpha, interleukin (IL)-1 beta, ICAM-1, and vascular cell adhesion molecule (VCAM)-1, which were reduced in the PDTC group. Immunohistochemical study demonstrated that the expression levels of TNF-alpha, ICAM-1, and MPO were all increased in the SAH group, but these increases were attenuated in the PDTC group. Our results suggest that NF-kappaB is activated in the arterial wall after SAH, which potentially leads to vasospasm development through induction of inflammatory response. 相似文献